Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Dizziness and Lightheadedness: Transient dizziness following injection is reported anecdotally, attributed to vasodilatory effects of the nitric oxide pathway activated by BPC-157
caution in methylation disorders (use only under supervision) No known drug interactions with oral medications, but B12 may mask B9 (folate) deficiencycombined B-vitamin status should be assessed periodically
After five months of testing on patients with nonsegmental vitiligo, the researchers found that MT1 therapy coupled with NBUV-B phototherapy produced statistically significant superior and faster repigmentation compared with monotherapy, especially in the face and upper extremities [7, 8]
On April 22, 2026, BPC-157 was removed from Category 2 because the original nominator withdrew
pylori infection may be warranted if symptoms persist
10.1016/s0305-4179(01)00055-9 78 MiyamotoS.TakaokaK.OkadaT.YoshikawaH.HashimotoJ.SuzukiS.et al (1992)
